Other providers build assays.

We build therapies.

We’re developing our own cell therapy to treat Type 1 Diabetes, so our range of analytical and molecular diagnostic tests have been developed to meet international manufacturing and clinical monitoring regulations from the outset. Using predominantly molecular methods we provide the accuracy, quantitation and speed of result that your, and our, advanced therapeutic medical products require. 

We innovate for you

We are committed to keeping pace with your innovation and introducing rapid analytical and diagnostic methods into your manufacturing and clinical development that go beyond slow, outdated methods, whilst still meeting the US, EU and British regulatory and pharmacopoeia standards.

When you need to go beyond the norm, we offer you the opportunity to expediently and cost effectively develop validated assays that are specific to your product’s manufacturing and clinical needs.

Rapid Microbial QC

Sterility

Endotoxin

Mycoplasma

Viral/Biosafety

Adventitious viral agents

Replication competent lentivirus / retrovirus (RCL/RCR) detection

Viral vector copy number

Donor viral screening panel (including zoonotic viruses)

Residual contaminants: viral vector, plasmid and host-cell DNA and proteins

Xenotransplantation

DPF herd establishment & monitoring.

PERV screening.

Zoonotic viruses, fungi, parasites

Contact us for a consultation

Clinical bioassays

Sample accessioning and cyropreservation

Nucleic acid biomarkers

Genotyping

Cytokine/chemokine profiling

Cell activation/exhaustion markers

Tumour or disease associated biomarkers

Protein and peptide evaluation

Target engagement biomarkers

Cell expansion/persistence analysis

Surrogate markers